PMID: 9557945Apr 29, 1998Paper

Prostaglandins act as neurotoxin for differentiated neuroblastoma cells in culture and increase levels of ubiquitin and beta-amyloid

In Vitro Cellular & Developmental Biology. Animal
K N PrasadJ E Prasad

Abstract

Although chronic inflammatory reactions have been proposed to cause neuronal degeneration associated with Alzheimer's disease (AD), the role of prostaglandins (PGs), one of the secretory products of inflammatory reactions, in degeneration of nerve cells has not been studied. Our initial observation that PGE1-induced differentiated neuroblastoma (NB) cells degenerate in vitro more rapidly than those induced by RO20-1724, an inhibitor of cyclic nucleotide phosphodiesterase, has led us to postulate that PGs act as a neurotoxin. This study has further investigated the effects of PGs on differentiated NB cells in culture. Results showed that PGA1 was more effective than PGE1 in causing degeneration of differentiated NB cells as shown by the cytoplasmic vacuolation and fragmentation of soma, nuclei, and neurites. Because increased levels of ubiquitin and beta-amyloid have been implicated in causing neuronal degeneration, we studied the effects of PGs on the levels of these proteins during degeneration of NB cells in vitro by an immunostaining technique, using primary antibodies to ubiquitin and beta-amyloid. Results showed that PGs increased the intracellular levels of ubiquitin and beta-amyloid prior to degeneration, whereas the deg...Continue Reading

References

Mar 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·I L Goldknopf, H Busch
Jul 1, 1992·Research in Immunology·F BerkenboschA M van Dam
May 11, 1992·Annals of the New York Academy of Sciences·J S RichardsonL C Ang
Nov 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·J RogersP Ward
Sep 1, 1992·Neurobiology of Aging·D GamesI Lieberburg
Sep 1, 1992·Neurobiology of Aging·B Stein-BehrensR Sapolsky
Sep 1, 1992·Neurobiology of Aging·J A Clemens, D T Stephenson
Dec 15, 1992·Biochemical and Biophysical Research Communications·J B DavisD Schubert
Jan 1, 1992·Alzheimer Disease and Associated Disorders·C L Joachim, D J Selkoe
Oct 1, 1991·Trends in Pharmacological Sciences·J Hardy, D Allsop
Nov 1, 1991·Biological Reviews of the Cambridge Philosophical Society·K N Prasad
Dec 6, 1991·Brain Research·G P WangI Grundke-Iqbal
Apr 28, 1990·Lancet·P L McGeerJ Sibley
Nov 1, 1990·Neurology·G A BroeJ C Anthony
Mar 14, 1990·Neuroscience Letters·J S WhitsonC W Cotman
Jan 1, 1987·Annual Review of Cell Biology·M Rechsteiner
Feb 1, 1989·British Journal of Rheumatology·M L JenkinsonD L Scott
May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·G PerryV Chau
Jun 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·V A FriedK Weiner
Oct 24, 1980·Nucleic Acids Research·M H West, W M Bonner
Nov 7, 1995·Proceedings of the National Academy of Sciences of the United States of America·B D GitterP C May
Mar 15, 1994·Biochemical and Biophysical Research Communications·A KlegerisP L McGeer
Aug 1, 1994·The American Journal of Psychiatry·P S Aisen, K L Davis
Jul 1, 1995·European Journal of Biochemistry·H P Jennissen
Apr 1, 1995·Trends in Neurosciences·M A SmithG Perry
Jan 1, 1995·Neurology·J B RichJ Brandt
Dec 1, 1994·Trends in Pharmacological Sciences·P EikelenboomD Allsop
Jul 1, 1994·Neurobiology of Aging·N K Robakis, M A Pappolla
Jan 1, 1994·Pharmacology & Therapeutics·M E GötzM B Youdim
Jan 1, 1994·Neurobiology of Aging·Y T LiJ Q Trojanowski
Jul 1, 1993·British Medical Bulletin·P H Evans
Aug 1, 1993·Neurology·J RogersP Willson
Feb 1, 1993·Journal of the American Geriatrics Society·W B Ershler

❮ Previous
Next ❯

Citations

Sep 29, 2007·Journal of Molecular Neuroscience : MN·X LiangK Andreasson
Aug 24, 1999·Neurochemistry International·A R HovlandK N Prasad
Apr 4, 2003·The International Journal of Biochemistry & Cell Biology·Zongmin LiMaria E Figueiredo-Pereira
Mar 21, 2006·Biochemistry. Biokhimii︠a︡·A I Hubich, M V Sholukh
Aug 24, 2013·Clinical & Developmental Immunology·Elisa RidolfiDaniela Galimberti
May 11, 2006·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Akhlaq A Farooqui, Lloyd A Horrocks
Jan 21, 2006·Pediatric Blood & Cancer·Patricia AlcasabasSüreyya Savaşan
Mar 30, 2001·The Journal of Biological Chemistry·M KondoK Uchida
Apr 25, 2001·Journal of Neuroscience Research·A Rudie HovlandK N Prasad
Mar 18, 2000·Proceedings of the Society for Experimental Biology and Medicine·A CampbellS C Bondy
Oct 11, 2020·Prostaglandins & Other Lipid Mediators·Christian CodePaavo K J Kinnunen
Jul 6, 2000·Japanese Journal of Pharmacology·K SugayaH Manev

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.